Novus Biologicals products are now on bio-techne.com

Recombinant Human VEGF-C (Cys156Ser) Protein

Images

 
There are currently no images for VEGF-C (752-VC).

Every product we sell is backed by Novus' 100% Guarantee. If you have used this product, please submit your images and reviews to earn reward points.

Product Details

Summary
Reactivity HuSpecies Glossary
Applications Binding Activity, Bioactivity

Order Details

View Available Formulations
Catalog# & Formulation Size Price

Recombinant Human VEGF-C (Cys156Ser) Protein Summary

Details of Functionality
Measured in a cell proliferation assay using HMVEC human microvascular endothelial cells. Marconcini, L. et al. (1999) Proc. Natl. Acad. Sci. USA 96:9671. The ED50 for this effect is 1-5 µg/mL. Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human VEGF R3/Flt‑4 Fc Chimera (Catalog # 349-F4) at 5 µg/mL (100 µL/well) can bind  Recombinant Human VEGF‑C (Cys156Ser) with an apparent Kd <40 nM.
Source
Mouse myeloma cell line, NS0-derived human VEGF-C protein
Thr103-Arg227 (Cys156Ser), with a C-terminal 10-His tag
Accession #
N-terminal Sequence
Thr103
Protein/Peptide Type
Recombinant Proteins
Gene
VEGFC
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Binding Activity
  • Bioactivity
Theoretical MW
15.4 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
22-24 kDa, reducing conditions
Publications
Read Publications using
752-VC in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human VEGF-C (Cys156Ser) Protein

  • Flt4 ligand
  • Flt4-L
  • vascular endothelial growth factor C
  • Vascular endothelial growth factor-related protein
  • VEGFC
  • VEGF-C
  • VRPFLT4 ligand DHM

Background

Vascular endothelial growth factor C (VEGF-C) and VEGF-D constitute a subfamily of the angiogenic VEGF angiogenic factors (1). VEGF-C is synthesized as a 58 kDa molecule that consists of a VEGF homolgy domain (VHD) flanked by N- and C-terminal propeptides. The proprotein undergoes covalent homodimerization and stepwise proteolytic processing to generate ligands with increasing affinity for VEGF R3/Flt-4 (2-4). Fully processed VEGF-C containing just the 21 kDa VHD can additionally bind and activate VEGF R2/KDR/Flk-1 (2, 4). Fully processed human VEGF-C shares 98% amino acid sequence identity with mouse and rat VEGF-C. VEGF-C interactions with VEGF R3 are critical for lymphangiogenesis (5-8). VEGF-C and VEGF R3 are usually co-expressed at sites with lymphatic vessel sprouting, in the embryo, and in various pathological conditions. Over-expression of VEGF-C in tumor cells induces tumoral lymphatic hyperplasia, resulting in enhanced lymph flow and metastasis to regional lymph nodes (9-12). It also induces physiological and intratumoral neoangiogenesis and vessel sprouting through interactions with VEGF R2 (8, 13, 14).
  1. Chen, J.-C. et al. (2013) Int. J. Mol. Sci. 14:88.
  2. Joukov, V. et al. (1996) EMBO J. 15:290.
  3. Kukk, E. et al. (1996) Development 122:3829.
  4. Joukov, V. et al. (1997) EMBO J. 16:3898.
  5. Karkkainen, M. et al. (2004) Nat. Immunol. 5:74.
  6. Jeltsch, M. et al. (1997) Science 276:1423.
  7. Makinen, T. et al. (2001) Nat. Med. 7:199.
  8. Laakkonen, P. et al. (2007) Cancer Res. 67:593.
  9. Hoshida, T. et al. (2006) Cancer Res. 66:8065.
  10. Mandriota, S.J. et al. (2001) EMBO J. 20:672.
  11. Skobe, M. et al. (2001) Nat. Med. 7:192.
  12. Padera, T.P. et al. (2002) Science 296:1883.
  13. Tammela, T. et al. (2008) Nature 454:656.
  14. Cao, Y. et al. (1998) Proc. Natl. Acad. Sci. 95:14389.

Customers Who Viewed This Item Also Viewed...

DVE00
Species: Hu
Applications: ELISA
DVED00
Species: Hu
Applications: ELISA
AF743
Species: Mu
Applications: CyTOF-ready, Flow, WB
AF2125
Species: Mu
Applications: Dual ISH-IHC, IHC, WB
AF644
Species: Mu
Applications: CyTOF-ready, Dual ISH-IHC, Flow, IHC, Neut, WB
AF321
Species: Hu
Applications: Block, CyTOF-ready, Flow, IHC, WB
NB100-689
Species: Hu, Rt
Applications: IHC, IHC-Fr, IHC-P, Simple Western, WB
DPG00
Species: Hu
Applications: ELISA
233-FB
Species: Hu
Applications: BA
AF751
Species: Hu
Applications: WB
AF751
Species: Hu
Applications: WB
AF3628
Species: Hu, Mu, Rt
Applications: CyTOF-ready, Flow, ICC, IHC, WB
NB110-41083
Species: Hu
Applications: ChIP, ELISA, ICC/IF, WB
AF4117
Species: Rt
Applications: IHC, WB
NBP1-33050
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, WB

Publications for VEGF-C (752-VC)(21)

We have publications tested in 3 confirmed species: Human, Mouse, Xenopus.

We have publications tested in 3 applications: Bioassay, Cell Culture, In Vivo.


Filter By Application
Bioassay
(12)
Cell Culture
(1)
In Vivo
(9)
All Applications
Filter By Species
Human
(11)
Mouse
(11)
Xenopus
(1)
All Species
Showing Publications 1 - 10 of 21. Show All 21 Publications.
Publications using 752-VC Applications Species
Wang, YJ;Zheng, Y;Cong, L;Wang, P;Zhao, L;Xing, L;Liu, J;Xu, H;Li, N;Zhao, Y;Shi, Q;Liang, Q; Lymphatic platelet thrombosis limits bone repair by precluding lymphatic transporting DAMPs Research square 2023-11-14 [PMID: 38014223] (In Vivo, Mouse) In Vivo Mouse
Choi, YH;Hsu, M;Laaker, C;Herbath, M;Yang, H;Cismaru, P;Johnson, AM;Spellman, B;Wigand, K;Sandor, M;Fabry, Z; Dual role of Vascular Endothelial Growth Factor-C (VEGF-C) in post-stroke recovery bioRxiv : the preprint server for biology 2023-09-01 [PMID: 37693558] (In Vivo, Mouse) In Vivo Mouse
Babaei, Z;Panjehpour, M;Parsian, H;Aghaei, M; SAR131675 exhibits anticancer activity on human ovarian cancer cells through inhibition of VEGFR-3/ERK1/2/AKT signaling pathway Cellular signalling 2023-08-19 [PMID: 37598918] (Bioassay, Human) Bioassay Human
S Dutta, NS Polavaram, R Islam, S Bhattachar, S Bodas, T Mayr, S Roy, SAY Albala, MI Toma, A Darehshour, A Borkowetz, S Conrad, S Fuessel, M Wirth, GB Baretton, LC Hofbauer, P Ghosh, KJ Pienta, DL Klinkebiel, SK Batra, MH Muders, K Datta Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer Oncogene, 2022-06-27;0(0):. 2022-06-27 [PMID: 35754042] (Bioassay, Human) Bioassay Human
A Chakrabort, R Upadhya, TA Usman, AK Shetty, JM Rutkowski Chronic VEGFR-3 signaling preserves dendritic arborization and sensitization under stress Brain, Behavior, and Immunity, 2021-08-11;0(0):. 2021-08-11 [PMID: 34389489] (Bioassay, Human) Bioassay Human
Y Shimizu, R Polavarapu, KL Eskla, Y Pantner, CK Nicholson, M Ishii, D Brunnhoelz, R Mauria, A Husain, N Naqvi, T Murohara, JW Calvert Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury J Am Heart Assoc, 2018-10-02;7(19):e009565. 2018-10-02 [PMID: 30371303] (Bioassay, Human) Bioassay Human
JM Vieira, S Norman, C Villa Del, TJ Cahill, DN Barnette, M Gunadasa-R, LA Johnson, DR Greaves, CA Carr, DG Jackson, PR Riley The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction J. Clin. Invest., 2018-07-09;0(0):. 2018-07-09 [PMID: 29985167] (In Vivo, Mouse) In Vivo Mouse
YR Wen, JH Yang, X Wang, ZB Yao Induced dural lymphangiogenesis facilities soluble amyloid-beta clearance from brain in a transgenic mouse model of Alzheimer&#039;s disease Neural Regen Res, 2018-04-01;13(4):709-716. 2018-04-01 [PMID: 29722325] (Bioassay, In Vivo, Human, Mouse) Bioassay, In Vivo Human, Mouse
K Rauniyar, SK Jha, M Jeltsch Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels Front Bioeng Biotechnol, 2018-02-12;6(0):7. 2018-02-12 [PMID: 29484295] (Cell Culture, Human) Cell Culture Human
Louveau A, Smirnov I, Keyes T, Eccles J, Rouhani S, Peske J, Derecki N, Castle D, Mandell J, Lee K, Harris T, Kipnis J Structural and functional features of central nervous system lymphatic vessels. Nature, 2015-06-01;523(7560):337-41. 2015-06-01 [PMID: 26030524] (In Vivo, Mouse) In Vivo Mouse
Show All 21 Publications.

Reviews for VEGF-C (752-VC) (0)

There are no reviews for VEGF-C (752-VC). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for VEGF-C (752-VC). (Showing 1 - 1 of 1 FAQs).

  1. I was wondering if you know of any blocking antibodies against IL-6 or VEGF-C that can be used in cell culture to quench these cytokines?
    • We have no antibodies that are currently known to show blocking antibodies to VEGF-C. Please see this link to our IL-6 antibodies with blocking/neutralizing activity can be found at this link.

Additional VEGF-C Products

Blogs on VEGF-C

There are no specific blogs for VEGF-C, but you can read our latest blog posts.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human VEGF-C (Cys156Ser) Protein and receive a gift card or discount.

Bioinformatics

Gene Symbol VEGFC
Uniprot